Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Reumatologia|November 23, 2020
Liver involvement in rheumatic diseasesJoanna Podgórska, Paulina Werel, Jakub Klapaczyński, et al.Clinical and Experimental Hepatology|December 19, 2024
Treatment of HCV infection in patients with steatotic liver diseaseRobert Flisiak, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, et al.Cell Communication and Signaling : CCS|January 3, 2024
Liver damage profile in COVID-19 pregnant patientsMarcin Januszewski, Laura Ziuzia-Januszewska, Michal Kudan, et al.Polish Archives of Internal Medicine|July 24, 2025
Clinical characteristics of patients with primary biliary cholangitis treated with ursodeoxycholic acidMagdalena Rogalska, Aleksandra Berkan-Kawińska, Jakub Klapaczyński, et al.Polish Archives of Internal Medicine|April 14, 2026
Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?Kinga Brzdęk, Dorota Zarębska-Michaluk, Beata Lorenc, et al.BMC Medicine|October 24, 2024
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationDorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, et al.Journal of Clinical Medicine|January 21, 2022
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV CoinfectionDorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, et al.Journal of Personalized Medicine|July 29, 2023
Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in PolandMonika Pazgan-Simon, Jerzy Jaroszewicz, Krzysztof Simon, et al.Clinical and Experimental Hepatology|October 4, 2023
Pangenotypic triple <i>versus</i> double therapy in HCV-infected patients after prior failure of direct-acting antiviralsRobert Flisiak, Dorota Zarębska-Michaluk, Hanna Berak, et al.Minerva Medica|April 9, 2024
Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly peopleMichał Brzdęk, Dorota Zarębska-Michaluk, Krzysztof Tomasiewicz, et al.Pageof 4